The Sclera pp 241-276 | Cite as

Infectious Scleritis

  • Maite Sainz de la Maza
  • Joseph Tauber
  • C. Stephen Foster


Although immune-mediated diseases are the main disorders associated with scleritis, other, less common etiologies, such as infections, must also be considered. Infectious agents, such as bacteria, fungi, viruses, and parasites, may cause scleritis through a direct invasion or through an immune response. Infectious scleritis should be suspected in cases of indolent progressive scleral necrosis with suppuration, especially if the past and present history reveals an accidental trauma, chronic topical medication use (including corticosteroids), surgical procedures, or debilitating ocular or systemic disease; they also should be suspected if the review of systems reveal multisystem findings compatible with a systemic infection. In exogenous and endogenous infections, scrapings for smears and cultures must be obtained and fortified antimicrobial therapy, depending on smear results, must be initiated as soon as possible.


Herpes Zoster Lyme Disease Anterior Uveitis Herpes Simplex Virus Infection Congenital Syphilis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Reynolds MG, Alfonso E. Infectious scleritis and kerato­scleritis: management and outcome. Am J Ophthalmol. 1991;112:543.PubMedGoogle Scholar
  2. 2.
    Alfonso E, Kenyon KR, Ormerod LD, Stevens R, Wagoner MD, Albert DM. Pseudomonas corneoscleritis. Am J Ophthalmol. 1987;103:90.PubMedGoogle Scholar
  3. 3.
    Meallet MA. Subpalpebral lavage antibiotic treatment for severe infectious scleritis and keratitis. Cornea. 2006;25:159.PubMedCrossRefGoogle Scholar
  4. 4.
    Raber IM, Laibson PR, Kurz GH, Bernardino VB. Pseudomonas corneoscleral ulcers. Am J Ophthalmol. 1981;92:353.PubMedGoogle Scholar
  5. 5.
    Lee JE, Oum BS, Choi HY, Lee JS. Methicillin-resistant Staphylococcus aureus sclerokeratitis after pterigium excision. Cornea. 2007;26:744.PubMedCrossRefGoogle Scholar
  6. 6.
    Nanda M, Pflugfelder SC, Holland S. Fulminant pseudomonal keratitis and scleritis in human immunodeficiency virus-infected patients. Arch Ophthalmol. 1991;109:503.PubMedCrossRefGoogle Scholar
  7. 7.
    Farrell PLR, Smith RE. Bacterial corneoscleritis complicating pterygium excision. Am J Ophthalmol. 1989;107:515.PubMedGoogle Scholar
  8. 8.
    Rich RM, Smiddy WE, Davis JL. Infectious scleritis after retinal surgery. Am J Ophthalmol. 2008;145:695.PubMedCrossRefGoogle Scholar
  9. 9.
    Tarr KH, Constable IJ. Late complications of pterygium treatment. Br J Ophthalmol. 1980;64:496.PubMedCrossRefGoogle Scholar
  10. 10.
    Tarr KH, Constable IJ. Pseudomonas endophthalmitis associated with scleral necrosis. Br J Ophthalmol. 1980;64:676.PubMedCrossRefGoogle Scholar
  11. 11.
    Tarr KH, Constable IJ. Radiation damage after pterygium treatment. Aust J Ophthalmol. 1981;9:97.PubMedCrossRefGoogle Scholar
  12. 12.
    Berler DK, Alper MG. Scleral abscesses and ectasia caused by Pseudomonas aeruginosa. Ann Ophthalmol. 1982;14:665.PubMedGoogle Scholar
  13. 13.
    Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994;101:389.PubMedGoogle Scholar
  14. 14.
    Sainz de la Maza M, Foster CS. Necrotizing scleritis after ocular surgery. Ophthalmology. 1991;98:1720.PubMedGoogle Scholar
  15. 15.
    Lin HC, Ma DH, Chen YF, et al. Late-onset intrascleral dissemination of Stenotrophomonas maltophilia scleritis after pterygium excision. Cornea. 2011;30:712.PubMedCrossRefGoogle Scholar
  16. 16.
    Zinn KM, Ferry AP. Massive scleral necrosis from a Pseudomonas infection following scleral buckling and pars plana vitrectomy surgery. Mt Sinai J Med. 1980;47:618.PubMedGoogle Scholar
  17. 17.
    Ramos-Esteban JC, Jeng BH. Posttraumatic Stenotrophomonas maltophilia infectious scleritis. Cornea. 2008;27:232.PubMedCrossRefGoogle Scholar
  18. 18.
    Jackson WB. Infections of the sclera. In: Tabbara KF, Hyndiuk RA, editors. Infections of the eye. Boston: Little, Brown, and Company; 1986, Chap 28.Google Scholar
  19. 19.
    Friedman AH, Henkind P. Unusual cases of episcleritis. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:890.Google Scholar
  20. 20.
    Harbin T. Recurrence of a corneal pseudomonal infection. Am J Ophthalmol. 1964;58:670.PubMedGoogle Scholar
  21. 21.
    Alpren TVP, Hyndiuk RA, Davis SD, et al. Cryotherapy for experimental pseudomonas keratitis. Arch Ophthalmol. 1979;97:711.PubMedCrossRefGoogle Scholar
  22. 22.
    Turner L, Stinson I. Mycobacterium fortuitum as a cause of corneal ulcer. Am J Ophthalmol. 1965;60:329.PubMedGoogle Scholar
  23. 23.
    Zimmerman LE, Turner L, McTigue JW. Mycobacterium fortuitum infection of the cornea. Arch Ophthalmol. 1969;82:596.PubMedCrossRefGoogle Scholar
  24. 24.
    Gangadharam PRJ, Lanier JD, Jones DE. Keratitis due to Mycobacterium chelonei. Tubercle. 1978;59:55.PubMedCrossRefGoogle Scholar
  25. 25.
    Newman PE, Goodman RA, Waring GO, et al. A cluster of cases of Mycobacterium chelonae keratitis associated with outpatient office procedures. Am J Ophthalmol. 1984;97:344.PubMedGoogle Scholar
  26. 26.
    Moore MB, Newton C, Kaufman HE. Chronic keratitis caused by Mycobacterium gordonae. Am J Ophthalmol. 1986;102:516.PubMedGoogle Scholar
  27. 27.
    Laflamme MY, Poisson M, Chéhadé N. Mycobacterium chelonae keratitis following penetrating keratoplasty. Can J Ophthalmol. 1987;22:178.PubMedGoogle Scholar
  28. 28.
    Metta H, Corti M, Brunzini R. Disseminated infection due to Mycobacterium chelonae with scleritis, spondylodiscitis and spinal epidural abscess. Braz J Infect Dis. 2008;12:260.PubMedCrossRefGoogle Scholar
  29. 29.
    Schönherr U, Naumann GOH, Lang GK, et al. Sclerokeratitis by Mycobacterium marinum. Am J Ophthalmol. 1989;108:607.PubMedGoogle Scholar
  30. 30.
    Carson LA, Peterson NJ, Favero MS, et al. Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl Environ Microbiol. 1978;36:839.PubMedGoogle Scholar
  31. 31.
    Jolly HW, Seabury JH. Infections with Mycobacterium marinum. Arch Dermatol. 1972;106:32.PubMedCrossRefGoogle Scholar
  32. 32.
    Zeligman I. Mycobacterium marinum granuloma. Arch Dermatol. 1972;106:26.PubMedCrossRefGoogle Scholar
  33. 33.
    Spencer WH. Ophthalmic pathology. An atlas and textbook. 3rd ed. Philadelphia: WB Saunders; 1985. p. 275–7.Google Scholar
  34. 34.
    Kubica GP. Differential identification of mycobacteria. VII. Key features for identification of clinically significant mycobacteria. Am Rev Respir Dis. 1973;107:9.PubMedGoogle Scholar
  35. 35.
    Wolinsky E. Nontuberculous mycobacterial infections of man. Med Clin North Am. 1974;58:639.PubMedGoogle Scholar
  36. 36.
    Donahue HC. Ophthalmologic experience in a tuberculosis sanatorium. Am J Ophthalmol. 1967;64:742.PubMedGoogle Scholar
  37. 37.
    Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60:163.PubMedCrossRefGoogle Scholar
  38. 38.
    Nanda M, Pflugfelder SC, Holland S. Mycobacterium tuberculosis scleritis. Am J Ophthalmol. 1989;108:736.PubMedGoogle Scholar
  39. 39.
    Glassroth J, Robins AG, Snider Jr DE. Tuberculosis in the 1980’s. N Engl J Med. 1980;302:1441.PubMedCrossRefGoogle Scholar
  40. 40.
    Shumomura Y, Tader R, Yuam T. Ocular disorders in pulmonary tuberculosis. Folia Ophthalmol Jpn. 1979;30:1973.Google Scholar
  41. 41.
    Phillips S, Williams ML, Maiden SD. Chronic miliary tuberculosis. Am Rev Tuberc. 1950;62:549.PubMedGoogle Scholar
  42. 42.
    Bloomfield SE, Mondino B, Gray GF. Scleral tuberculosis. Arch Ophthalmol. 1976;94:954.PubMedCrossRefGoogle Scholar
  43. 43.
    Bell GH. Report of a case of tuberculosis of the sclera of probable primary origin. Trans Am Ophthalmol Soc. 1914;13:787.PubMedGoogle Scholar
  44. 44.
    Swan KC. Some comtemporary concepts of scleral disease. Arch Ophthalmol. 1951;45:630.CrossRefGoogle Scholar
  45. 45.
    Finnoff WC. Tuberculosis in etiology of acute iritis. Am J Ophthalmol. 1931;14:127.Google Scholar
  46. 46.
    Brini A, Quéré M, Achard M. Sclerite nodulaire nécrosante (presence de bacille de Koch). Bull Soc d’Ophtalmol France. 1953;7:822.Google Scholar
  47. 47.
    Andreani DG. Tuberculoma of the sclera. G Ital Oftalmol. 1954;7:506.Google Scholar
  48. 48.
    Woods AC. Ocular tuberculosis. In: Sorsby A, editor. Modern ophthalmology. Philadelphia: Lippincott; 1972. p. 105.Google Scholar
  49. 49.
    Sarda RP, Mehrotra AS, Asnani K. Nodular episcleritis (a proved case of tubercular origin). Indian J Ocul Pathol. 1969;3:24.Google Scholar
  50. 50.
    Thygeson PL. The etiology and treatment of phlyctenular keratoconjunctivitis. Am J Ophthalmol. 1975;9:446.Google Scholar
  51. 51.
    Smith RE, Dippe DW, Miller SD. Phlyctenular keratoconjunctivitis. Results of penetrating keratoplasty in Alaskan natives. Ophthalmic Surg. 1975;6:62.Google Scholar
  52. 52.
    Shepard CC. The experimental disease that follows the injection of human leprosy bacilli into footpads of mice. J Exp Med. 1960;112:445.PubMedCrossRefGoogle Scholar
  53. 53.
    Bechelli LM, Dominguez UM. The leprosy problem in the world. Bull WHO. 1966;34:811.PubMedGoogle Scholar
  54. 54.
    Shepard CC. Leprosy. In: Harrison TR, editor. Principles of Internal Medicine. New York: McGraw-Hill; 1980. p. 711–4.Google Scholar
  55. 55.
    Cochran RG. The classification of leprosy. Lepr Rev. 1946;17:36.Google Scholar
  56. 56.
    Van Voorhis WC, Kaplan G, Sarno EN, et al. The cutaneous infiltrates of leprosy. N Engl J Med. 1982;307:1593.PubMedCrossRefGoogle Scholar
  57. 57.
    De Barros JM. Aspectos clinicos do comprolimento ocular da lepra. Companhia Melhoramentos: Sao Paulo; 1939.Google Scholar
  58. 58.
    Brand ME. Early ocular changes in leprosy. London: IX International Leprosy Conference; 1968.Google Scholar
  59. 59.
    Schwab IR. Ocular leprosy. In: Tabbara JF, Hyndiuk RA, editors. Infections of the Eye. Boston: Little Brown; 1986. p. 613–24.Google Scholar
  60. 60.
    King EF. Eye in leprosy. Br J Ophthalmol. 1936;20:561.PubMedCrossRefGoogle Scholar
  61. 61.
    Allen JH, Byers JL. The pathology of ocular leprosy. Arch Ophthalmol. 1960;64:216.PubMedCrossRefGoogle Scholar
  62. 62.
    Ffitche TJ. Role of iris changes as a cause of blindness in lepromatous leprosy. Br J Ophthalmol. 1981;65:231.CrossRefGoogle Scholar
  63. 63.
    Holmes KK, Lukehart SA. Syphilis. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al., editors. Harrison’s principles of internal medicine, vol. 1. 11th ed. New York: McGraw-Hill; 1987. p. 639–49.Google Scholar
  64. 64.
    Centers for Disease Control. Summary-cases of specified notifiable diseases United States. MMWR. 1989;37:802.Google Scholar
  65. 65.
    Tamesis RR, Foster CS. Ocular syphilis. Ophthalmology. 1990;97:1281.PubMedGoogle Scholar
  66. 66.
    Johns DR, Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med. 1987;316:1569.PubMedCrossRefGoogle Scholar
  67. 67.
    Berry CD, Hooton TM, Collier AC, et al. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med. 1987;316:1587.PubMedCrossRefGoogle Scholar
  68. 68.
    Richards BW, Hessburg TJ, Nussbaum JN. Recurrent syphilitic uveitis. N Engl J Med. 1989;320:62.PubMedGoogle Scholar
  69. 69.
    Levy JH, Liss RA, Maguire AM. Neurosyphilis and ocular syphilis in patients with concurrent human immunodeficient virus infection. Retina. 1989;9:175.PubMedCrossRefGoogle Scholar
  70. 70.
    Zaidman GW. Neurosyphilis and retrobulbar neuritis in a patient with AIDS. Ann Ophthalmol. 1986;18:260.PubMedGoogle Scholar
  71. 71.
    Carter JB, Hamill RJ, Matoba AY. Bilateral syphilitic optic neuritis in a patient with a positive test for HIV. Arch Ophthalmol. 1987;105:1485.PubMedCrossRefGoogle Scholar
  72. 72.
    Kleiner RC, Najarian L, Levenson J, et al. AIDS complicated by syphilis can mimic uveitis and Crohn’s disease. Arch Ophthalmol. 1987;105:1486.PubMedCrossRefGoogle Scholar
  73. 73.
    Zambrano W, Perez GM, Smith JL. Acute syphilitic blindness in AIDS. J Clin Neuroophthalmol. 1987;7:1.PubMedCrossRefGoogle Scholar
  74. 74.
    Stoumbos VD, Klein ML. Syphilitic retinitis in a patient with acquired immunodeficiency syndrome-related complex. Am J Ophthalmol. 1987;103:103.PubMedGoogle Scholar
  75. 75.
    Radolf JD, Kaplan RP. Unusual manifestations of secondary syphilis and abnormal humoral immune response to Treponema Pallidum antigens in a homosexual man with asymptomatic human immunodeficiency virus infection. J Am Acad Dermatol. 1988;18:423.PubMedCrossRefGoogle Scholar
  76. 76.
    Passo MS, Rosembaum JT. Ocular syphilis in patients with human immunodeficiency virus infection. Am J Ophthalmol. 1988;106:1.PubMedGoogle Scholar
  77. 77.
    Wilhelmus KR. Syphilis. In: Insler MS, editor. AIDS and other sexually transmitted diseases and the eye. Orlando: Grune & Stratton; 1987. p. 73–104.Google Scholar
  78. 78.
    Wilhelmus KR, Yokoyama CM. Syphilitic episcleritis and scleritis. Am J Ophthalmol. 1987;104:595.PubMedGoogle Scholar
  79. 79.
    Evans JJ. Diffuse gummatous infiltration of scleral and episcleral tissues. Trans Ophthalmol Soc UK. 1905;25:188.Google Scholar
  80. 80.
    Watson PG, Hazleman BL. The sclera and systemic disorders. Philadelphia: W.B. Saunders; 1976. p. 206–346.Google Scholar
  81. 81.
    Deodati F, Bec P, Labro JB, et al. Sclérite syphilitique. Aspect clinique et angiographic. Bull Soc Ophthalmol Fr. 1971;71:63.Google Scholar
  82. 82.
    Spicer WTH. Parencymatous keratitis: Interstitial keratitis: Uveitis anterior. Br J Ophthalmol. 1924;(Monograph Suppl I):1.Google Scholar
  83. 83.
    Yobs AR, Brown L, Hunter EF. Fluorescent antibody technique in early syphilis. Arch Pathol. 1964;77:220.PubMedGoogle Scholar
  84. 84.
    Tourville DR, Byrd LH, Kim DU, et al. Treponemal antigen in immunopathogenesis of syphilitic glomerulonephritis. Am J Pathol. 1976;82:479.PubMedGoogle Scholar
  85. 85.
    Bansal RC, Cohn H, Fani K, et al. Nephrotic syndrome and granulomatous hepatitis. Arch Dermatol. 1978;114:1228.PubMedCrossRefGoogle Scholar
  86. 86.
    Beckett JH, Bigbee JW. Immunoperoxidase localization of Treponema Pallidum. Arch Pathol. 1979;103:135.Google Scholar
  87. 87.
    Trantas M. Bourrelet périkératique syphilitique. Arch Ophtalmol. 1911;31:320.Google Scholar
  88. 88.
    Bhaduri BN, Basu SK. Scleral gumma. Br J Ophthalmol. 1956;40:504.PubMedCrossRefGoogle Scholar
  89. 89.
    Spoor TC, Wynn P, Hartel WC, et al. Ocular syphilis: acute and chronic. J Clin Neuroophthalmol. 1983;3:197.PubMedGoogle Scholar
  90. 90.
    Harner RE, Smith JL, Israel CW. The FTA-ABS in late syphilis. A serological study in 1,985 cases. JAMA. 1968;203:545.PubMedCrossRefGoogle Scholar
  91. 91.
    Hart G. Syphilis tests in diagnostic and therapeutic decision making. Ann Intern Med. 1986;104:368.PubMedGoogle Scholar
  92. 92.
    Collart P, Poitevin M. Is penicillin therapy always infallible in syphilis? J Clin Neuroophthalmol. 1982;2:77.PubMedGoogle Scholar
  93. 93.
    Steere AC, Malawista SE, Snydman DR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 1977;20:7.PubMedCrossRefGoogle Scholar
  94. 94.
    Steere AC, Taylor E, Wilson ML, et al. Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population. J Infect Dis. 1986;154:295.PubMedCrossRefGoogle Scholar
  95. 95.
    Hanrahan JP, Benach JL, Coleman JL, et al. Incidence and cumulative frequency of endemic Lyme disease in a community. J Infect Dis. 1984;150:489.PubMedCrossRefGoogle Scholar
  96. 96.
    MacDonald AB. Lyme disease: a neuroophthalmologic view. J Clin Neuroophthalmol. 1987;7:185.PubMedCrossRefGoogle Scholar
  97. 97.
    Steere AC, Malawista SE. Cases of Lyme disease in the United States: locations correlated with the distribution of Ixodes damnini. Ann Intern Med. 1979;91:730.PubMedGoogle Scholar
  98. 98.
    Burgdorfer W, Keirans JE. Ticks and Lyme disease in the United States. Ann Intern Med. 1983;99:121.PubMedGoogle Scholar
  99. 99.
    Steere AC, Broderick TE, Malawista SE. Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector. Am J Epidemiol. 1978;108:312.PubMedGoogle Scholar
  100. 100.
    Burgdorfer W, Barbour AG, Hayes SF, et al. Lyme disease-a tick-borne spirochetosis? Science. 1982;216:1317.PubMedCrossRefGoogle Scholar
  101. 101.
    Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med. 1983;308:740.CrossRefGoogle Scholar
  102. 102.
    Benach JL, Busler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med. 1983;308:740.PubMedCrossRefGoogle Scholar
  103. 103.
    Steere Ac, Malawista SE, Hardin JA, et al. Erythema chronicum migrans and Lyme disease: the enlarging clinical spectrum. Ann Intern Med. 1977;86:685.PubMedGoogle Scholar
  104. 104.
    Steere AC, Bartenhagen NH, Craft JE, et al. The early clinical manifestations of Lyme disease. Ann Intern Med. 1983;99:76.PubMedGoogle Scholar
  105. 105.
    Reik L, Steere AC, Bartenhagen NH, et al. Neurologic abnormalities of Lyme disease. Medicine. 1979;58:281.PubMedCrossRefGoogle Scholar
  106. 106.
    Steere AC, Batsford WP, Weinberg M, et al. Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med. 1980;93:8.PubMedGoogle Scholar
  107. 107.
    Halperin JJ, Pass HL, Anand AK, et al. Nervous system abnormalities in Lyme disease. Ann N Y Acad Sci. 1988;539:24.PubMedCrossRefGoogle Scholar
  108. 108.
    Schmutzhard E, Pohl P, Stockhammer G, et al. Unusual neurological manifestations of second-stage Lyme borreliosis. Ann N Y Acad Sci. 1988;539:495.CrossRefGoogle Scholar
  109. 109.
    Schmutzhard E, Pohl P, Stanek G. Involvement of Borrelia burgdorferi incranial nerve affection. Zentralbl Bakteriol Mikrobiol Hyg. 1986;263:328.Google Scholar
  110. 110.
    Wallis RC, Brown SE, Kloter KO, Main Jr AJ. Erythema chronicum migrans and Lyme arthritis: field study of ticks. Am J Epidemiol. 1978;108:322.PubMedGoogle Scholar
  111. 111.
    Steere AC, Gibofsky A, Patarroyo ME, et al. Chronic Lyme arthritis: clinical and immunogenetic differentiation from rheumatoid arthritis. Ann Intern Med. 1979;90:896.PubMedGoogle Scholar
  112. 112.
    Steere AC, Brinckerhoff CE, Miller DJ, et al. Elevated levels of collagenase and prostaglandin E2 from synovium associated with erosion of cartilage and bone in a patient with chronic Lyme arthritis. Arthritis Rheum. 1980;23:591.PubMedCrossRefGoogle Scholar
  113. 113.
    Ar P, Steere AC. CNS manifestations of third stage Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg. 1986;263:301.Google Scholar
  114. 114.
    Stiernstedt G, Gustafsson R, Karlsson M, et al. Clinical manifestations and diagnosis of neuroborreliosis. Ann N Y Acad Sci. 1988;539:46.PubMedCrossRefGoogle Scholar
  115. 115.
    Kristoferitsch W, Sluga E, Graf M, et al. Neuropathy associated with acrodermatitis chronica atrophicans. Ann N Y Acad Sci. 1988;539:35.PubMedCrossRefGoogle Scholar
  116. 116.
    Ackermann R, Rehse-Küpper B, Gollner E, et al. Chronic neurologic manifestations of erythema migrans borreliosis. Ann N Y Acad Sci. 1988;539:16.PubMedCrossRefGoogle Scholar
  117. 117.
    Pachner AR, Duray P, Steere AC. Central nervous system manifestations of Lyme disease. Arch Neurol. 1989;46:790.PubMedCrossRefGoogle Scholar
  118. 118.
    Mandell H, Steere AC, Reinhardt BN, et al. Lack of antibodies to Borrelia burgdorferi in patients with amyotrophic lateral sclerosis. N Engl J Med. 1989;320:255.PubMedCrossRefGoogle Scholar
  119. 119.
    Lesser RL, Kornmehl EW, Pachner AR, et al. Neuro- ophthalmologic manifestations of Lyme disease. Ophthalmology. 1990;97:699.PubMedGoogle Scholar
  120. 120.
    Farris BK, Webb RM. Lyme disease and optic neuritis. J Clin Neuroophthalmol. 1988;8:73.Google Scholar
  121. 121.
    Finkel MF. Lyme disease and its neurologic complications. Arch Neurol. 1988;45:99.PubMedCrossRefGoogle Scholar
  122. 122.
    Wu G, Lincoff H, Ellsworth RM, et al. Optic disc edema and Lyme disease. Ann Ophthalmol. 1986;18:252.PubMedGoogle Scholar
  123. 123.
    Schechter SL. Lyme disease associated with optic neuropathy. Am J Med. 1986;81:143.PubMedCrossRefGoogle Scholar
  124. 124.
    Bialasiewicz AA, Ruprecht KW, Naumann GOH, et al. Bilateral diffuse choroiditis and exudative retinal detachments with evidence of Lyme disease. Am J Ophthalmol. 1988;105:419.PubMedCrossRefGoogle Scholar
  125. 125.
    Damrow T, Freedman H, Lane R, et al. Is Ixodes (Ixodiopsis) angustus a vector of Lyme disease in Washington State? West J Med. 1989;150:580.PubMedGoogle Scholar
  126. 126.
    Bruhn FW. Lyme disease. Am J Dis Child. 1984;138:467.PubMedGoogle Scholar
  127. 127.
    Baum J, Barza M, Weinstein P, et al. Bilateral keratitis as a manifestation of Lyme disease. Am J Ophthalmol. 1988;105:75.PubMedGoogle Scholar
  128. 128.
    Steere AC, Malawista SE, Bartenhagen NH, et al. The clinical spectrum and treatment of Lyme disease. Yale J Biol Med. 1984;57:453.PubMedGoogle Scholar
  129. 129.
    Bertuch AW, Rocco E, Schwartz EG, et al. Lyme disease: ocular manifestations. Ann Ophthalmol. 1988;20:376.PubMedGoogle Scholar
  130. 130.
    Orlin SE, Lauffer JL. Lyme disease keratitis. Am J Ophthalmol. 1989;107:678.PubMedGoogle Scholar
  131. 131.
    Kornmehl EW, Lesser RL, Jaros P, et al. Bilateral keratitis in Lyme disease. Ophthalmology. 1989;96:1194.PubMedGoogle Scholar
  132. 132.
    Flach AJ, Lavoie PE. Episcleritis, conjunctivitis, and keratitis as ocular manifestations of Lyme disease. Ophthalmology. 1990;97:973.PubMedGoogle Scholar
  133. 133.
    Zaidman GW. Episcleritis and symblepharon associated with Lyme disease. Am J Ophthalmol. 1990;109:487.PubMedGoogle Scholar
  134. 134.
    Pavan-Langston D. Manual of ocular diagnosis and therapy. 3rd ed. Boston: Little Brown; 1991.Google Scholar
  135. 135.
    Jones BR, Al-Hussaini KM, Dunlop EC. Infection by tric agent and other members of the Bedsonia group, with anote on Reiter’s disease. Trans Ophthalmol Soc UK. 1966;86:291.PubMedGoogle Scholar
  136. 136.
    Gordon MA. Aerobic pathogenic Actinomycetaceae. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ, editors. Manual of clinical microbiology. 4th ed. Washington, DC: American Society for Microbiology; 1985. p. 249–62.Google Scholar
  137. 137.
    Rifkind D, Marchioro TL, Schneck SA, et al. Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Am J Med. 1967;43:28.PubMedCrossRefGoogle Scholar
  138. 138.
    Young LS, Armstrong D, Blevins A, et al. Nocardia asteroides infection complicating neoplastic disease. Am J Med. 1971;50:356.PubMedCrossRefGoogle Scholar
  139. 139.
    Maruo H, Shiraishi A, Hara Y, et al. Necrotizing nocardial scleritis successfully treated with surgical debridement and topical polyvinyl alcohol iodine and antibiotics. J Ocul Pharmacol Ther. 2011;24(4):415–8.CrossRefGoogle Scholar
  140. 140.
    Seth RK, Gaudio PA. Nocardia asteroids necrotizing scleritis associated with subtenon triamcinolone acetonide injection. Ocul Immunol Inflamm. 2008;16:139.PubMedCrossRefGoogle Scholar
  141. 141.
    Ramos-Esteban JC, Servat JJ, Silva RS, et al. Necrotizing nocardial scleritis after combined penetrating keratoplasty and phacoemulsification with intraocular lens implantation: a case report and review of the literature. Arq Bras Oftalmol. 2007;70:355.PubMedCrossRefGoogle Scholar
  142. 142.
    Panijayanond P, Olsson CA, Spivack ML, et al. Intraocular nocardiosis in a renal transplant patient. Arch Surg. 1972;104:845.PubMedCrossRefGoogle Scholar
  143. 143.
    Kattan HM, Pflugfelder SC. Nocardia scleritis. Am J Ophthalmol. 1990;110:446.PubMedGoogle Scholar
  144. 144.
    Davidson S, Foerster HC. Intraocular nocardial abscess, endogenous. Trans Am Acad Ophthalmol Otolaryngol. 1967;71:847.PubMedGoogle Scholar
  145. 145.
    Meyer SL, Font RL, Shaver RP. Intraocular nocardiosis: report of three cases. Arch Ophthalmol. 1970;83:536.PubMedCrossRefGoogle Scholar
  146. 146.
    Hoeprich PD, Brandt D, Parker RH. Nocardial brain abscess cured with cycloserine and sulfonamides. Am J Med Sci. 1968;255:208.PubMedCrossRefGoogle Scholar
  147. 147.
    Stenson S, Brookner A, Rosenthal S. Bilateral endogenous necrotizing scleritis due to Aspergillus oryzae. Ann Ophthalmol. 1982;14:67.PubMedGoogle Scholar
  148. 148.
    Margo CE, Polack FM, Mood CI. Aspergillus panophthalmitis complicating treatment of pterygium. Cornea. 1988;7:285.PubMedCrossRefGoogle Scholar
  149. 149.
    Lincoff HA, McLean JM, Nano H. Scleral abscess, I. A complication of retinal detachment buckling procedures. Arch Ophthalmol. 1965;74:641.PubMedCrossRefGoogle Scholar
  150. 150.
    Milauskas AT, Duke JR. Mycotic scleral abscess: report of a case following a scleral buckling operation for retinal detachment. Am J Ophthalmol. 1967;63:951.PubMedGoogle Scholar
  151. 151.
    Slomovic AR, Forster RK, Gelender H. Lasiodiplodia theobromae panophthalmitis. Can J Ophthalmol. 1985;20:225.PubMedGoogle Scholar
  152. 152.
    Fincher T, Fulcher SF. Diagnostic and therapeutic challenge of Aspergillus flavus scleritis. Cornea. 2007;26:618.PubMedGoogle Scholar
  153. 153.
    Jhanji V, Yohendran J, Constantinou M, et al. Scedosporium scleritis or keratitis or both: case series. Eye Contact Lens. 2009;35:312.PubMedCrossRefGoogle Scholar
  154. 154.
    Chaillous J. Sporotrichose gommeuse disseminée, gomme intra-oculaire, perforation de la sclérotique. Ann Ocul. 1912;148:321.Google Scholar
  155. 155.
    Chung PC, Lin HC, Hwang YS, et al. Paecylomices lilacinus scleritis with secondary keratitis. Cornea. 2007;26:232.PubMedCrossRefGoogle Scholar
  156. 156.
    Su CY, Tsai JJ, Chang YC, et al. Immunologic and clinical manifestations of infectious scleritis after pterygium excision. Cornea. 2006;25:663.PubMedCrossRefGoogle Scholar
  157. 157.
    De Doncker RML, de Keizer RJW, Oosterhuis JA. Scleral melting in a patient with conjunctival rhinosporidiosis. Br J Ophthalmol. 1990;74:635.PubMedCrossRefGoogle Scholar
  158. 158.
    Weller T. Varicella and herpes zoster: changing concepts of the natural history, control, and importance of not so benign virus (part 1). N Engl J Med. 1983;309:1362.PubMedCrossRefGoogle Scholar
  159. 159.
    Dolin R, Reichman RC, Mazur MH, et al. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med. 1978;89:375.PubMedGoogle Scholar
  160. 160.
    Gershon AA, Steinberg SP. Antibody responses to varicella-zoster virus and the role of antibody in host defense. Am J Med Sci. 1981;282:12.PubMedCrossRefGoogle Scholar
  161. 161.
    Straus SE, Ostrove JM, Inchauspe G, et al. NIH conference varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med. 1988;108:221.PubMedGoogle Scholar
  162. 162.
    Weller T. Varicella and herpes zoster (part 2). N Engl J Med. 1983;309:1434.PubMedCrossRefGoogle Scholar
  163. 163.
    Kurland L. Descriptive epidemiology of selected neurological and myopathic disorders with particular reference to a survey in Rochester, Minnesota. J Chronic Dis. 1958;8:378.PubMedCrossRefGoogle Scholar
  164. 164.
    Ragozzino M. Population based study of herpes zoster and its sequelae. Medicine. 1982;61:310.PubMedCrossRefGoogle Scholar
  165. 165.
    Manalingam R, Wellish M, Wolf W, et al. Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med. 1990;323:627.CrossRefGoogle Scholar
  166. 166.
    Hyman RW, Ecker JR, Tenser RB. Varicella-zoster virus RNA in human trigeminal ganglia. Lancet. 1983;2:814.PubMedCrossRefGoogle Scholar
  167. 167.
    Liesegang TJ. Corneal complications from herpes zoster ophthalmicus. Ophthalmology. 1985;92:316.PubMedGoogle Scholar
  168. 168.
    Thomas M, Robertson W. Derminal transmission of a virus as a cause of shingles. Lancet. 1968;2:1349.Google Scholar
  169. 169.
    Scheie HG. Herpes zoster ophthalmicus. Trans Ophthalmol Soc UK. 1970;90:899.PubMedGoogle Scholar
  170. 170.
    Pavan-Langston D. Varicella-zoster ophthalmicus. Int Ophthalmol Clin. 1975;15(4):171.PubMedCrossRefGoogle Scholar
  171. 171.
    Liesegang T. The varicella zoster virus: systemic and ocular features. J Am Acad Dermatol. 1984;11:165.PubMedCrossRefGoogle Scholar
  172. 172.
    Womack LW, Liesegang TJ. Complications of herpes zoster ophthalmicus. Arch Ophthalmol. 1983;101:42.PubMedCrossRefGoogle Scholar
  173. 173.
    Tuft SJ, Watson PG. Progression of scleral disease. Ophthalmology. 1991;98:467.PubMedGoogle Scholar
  174. 174.
    Lyne AJ, Pitkeathley DA. Episcleritis and scleritis. Arch Ophthalmol. 1968;80:171.PubMedCrossRefGoogle Scholar
  175. 175.
    Liesegang TJ. Diagnosis and therapy of herpes zoster ophthalmicus. Ophthalmology. 1991;98:1216.PubMedGoogle Scholar
  176. 176.
    Penman GG. Scleritis as a sequel of herpes ophthalmicus. Br J Ophthalmol. 1931;15:585.PubMedCrossRefGoogle Scholar
  177. 177.
    Levy R, Lobstein A. Une complication rare du zona ophthalmique; l’atrophie sclérale avec perforation. Bull Soc d’Ophtalmol France. 1952;3:256.Google Scholar
  178. 178.
    Adelung JC. Skleralstaphylom nach Herpes zoster ophthalmicus. Klin Monbl Augenheilkd. 1951;118:620.Google Scholar
  179. 179.
    Arducci F, Capelli I. Scleral staphyloma after scleritis caused by herpes zoster. Annali di Ottalmologia. 1968;94:187.Google Scholar
  180. 180.
    Solomon AR. New diagnostic tests for herpes simplex and varicella-zoster infections. J Am Acad Dermatol. 1988;18:218.PubMedCrossRefGoogle Scholar
  181. 181.
    Koneman EW, Allen SD, Dowell Jr VR, et al. Color atlas and textbook of diagnostic microbiology. Philadelphia: JB Lippincott; 1988. p. 691–764.Google Scholar
  182. 182.
    Solomon AR, Rasmussen RE, Weiss JS. A comparison of the Tzanck smear and viral isolation in varicella and herpes zoster. Arch Dermatol. 1986;122:282.PubMedCrossRefGoogle Scholar
  183. 183.
    Schwartz JN, Cashwell F, Hawkins HK, et al. Necrotizing retinopathy with herpes zoster ophthalmicus: a light and electron microscopical study. Arch Pathol Lab Med. 1976;100:386.PubMedGoogle Scholar
  184. 184.
    Witmer R, Iwamoto T. Electron microscope observation of herpes-like particles in the iris. Arch Ophthalmol. 1968;79:331.PubMedCrossRefGoogle Scholar
  185. 185.
    Drew WL, Mintz L. Rapid diagnosis of varicella-zoster virus infection by direct immunofluorescence. Am J Clin Pathol. 1980;73:699.PubMedGoogle Scholar
  186. 186.
    Folkers E, Vreeswijk J, Oranje AP, et al. Rapid diagnosis in varicella and herpes zoster: re-evaluation of direct smears (Tzanck test) and electron microscopy including colloidal gold immuno-electron microscopy in comparison with virus isolation. Br J Dermatol. 1989;121:287.PubMedCrossRefGoogle Scholar
  187. 187.
    Frey HM, Steinberg SP, Gershon AA. Rapid diagnosis of varicella-zoster virus infections by countercurrent immunoelectrophoresis. J Infect Dis. 1981;143:274.PubMedCrossRefGoogle Scholar
  188. 188.
    Richman DD, Cleveland PH, Redfield DC, et al. Rapid viral diagnosis. J Infect Dis. 1984;149:298.PubMedCrossRefGoogle Scholar
  189. 189.
    Schmidt NJ. Varicella-zoster virus. In: Lemette EH, et al. editors. Manual of clinical microbiology. 4th ed. Washington, DC: American Society for Microbiology; 1985, Chap 66.Google Scholar
  190. 190.
    Harper DR, Grose C. IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination. J Infect Dis. 1989;159:444.PubMedCrossRefGoogle Scholar
  191. 191.
    Cobo LM, Foulks GN, Lyesegang T, et al. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology. 1986;93:763.PubMedGoogle Scholar
  192. 192.
    Cobo LM. Reduction of the ocular complications of herpes zoster ophthalmicus by oral acyclovir. Am J Med. 1988;85(Suppl 2A):90.PubMedGoogle Scholar
  193. 193.
    Zaal MJW, Maudga PC, Rietveld E, et al. Chronic ocular zoster. Curr Eye Res. 1991;10(Suppl):125.PubMedCrossRefGoogle Scholar
  194. 194.
    Tilson HH. Monitoring the safety of antivirals. The example of the acyclovir experience. Am J Med. 1988;85(Suppl 2A):116.PubMedGoogle Scholar
  195. 195.
    Keczkes K, Basheer A. Do corticosteroids prevent postherpetic neuralgia? Br J Dermatol. 1980;102:551.PubMedCrossRefGoogle Scholar
  196. 196.
    Post BT, Philbrick JT. Do corticosteroids prevent postherpetic neuralgia? A review of the evidence. J Am Acad Dermtol. 1988;18:605.CrossRefGoogle Scholar
  197. 197.
    Esman V, Kroon S, Peterslund NA, et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet. 1987;2:126.CrossRefGoogle Scholar
  198. 198.
    Bernstein JE, Bickers DR, Dahl NV. Treatment of chronic postherpetic neuralgia with topical capsaicin. A preliminary report. J Am Acad Dermatol. 1987;17:93.PubMedCrossRefGoogle Scholar
  199. 199.
    Bucci Jr FA, Gabriels CF, Krohel GB. Successful treatment of postherpetic neuralgia with capsaicin. Am J Ophthalmol. 1988;106:758.PubMedCrossRefGoogle Scholar
  200. 200.
    Watson PN, Evans RJ. Postherpetic neuralgia. A review. Arch Neurol. 1986;43:836.PubMedCrossRefGoogle Scholar
  201. 201.
    Walsh TD. Antidepressants in chronic pain. Clin Neuropharmacol. 1983;6:271.PubMedCrossRefGoogle Scholar
  202. 202.
    Max MB, Schafer SC, Culnane M, et al. Amitriptyline versus placebo in postherpetic neuralgia. Neurology. 1988;38:1427.PubMedGoogle Scholar
  203. 203.
    Watson CP, Evans RJ, Reed K, et al. Amitriptyline versus placebo in postherpetic neuralgia. Neurology. 1982;32:671.PubMedGoogle Scholar
  204. 204.
    Scott T. Epidemiology of herpetic infection. Am J Ophthalmol. 1957;43:134.PubMedGoogle Scholar
  205. 205.
    Lehner T, Wilton J, Shillitoe E. Immunological basis for latency, recurrences, and putative oncogenicity of herpes simplex virus. Lancet. 1975;2:60.PubMedCrossRefGoogle Scholar
  206. 206.
    Bhat PV, Jakobiec FA, Kurbanyan K, et al. Chronic herpes simplex scleritis: characterization of 9 cases of an underrecognized clinical entity. Am J Ophthalmol. 2009;148:779.PubMedCrossRefGoogle Scholar
  207. 207.
    Sainz de la Maza M, Wells PA, Foster CS. Cyclic nucleotide modulation of herpes simplex virus latency and reactivation. Invest Ophthalmol Vis Sci. 1989;30:2154.PubMedGoogle Scholar
  208. 208.
    Lam MT, Pazin GJ, Armstrong JA, et al. Herpes simplex infection in acute myelogenous leukemia and other hematologic malignancies. Cancer. 1981;48:2168.PubMedCrossRefGoogle Scholar
  209. 209.
    Leming PD, Martin SE, Zwelling LA. Atypical herpes simplex infection in a patient with Hodgkin’s disease. Cancer. 1984;54:3043.PubMedCrossRefGoogle Scholar
  210. 210.
    Centifanto-Fitzgerald YM, Yamaguchi T, Kaufman HE, et al. Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA. J Exp Med. 1982;155:475.PubMedCrossRefGoogle Scholar
  211. 211.
    Gerdes JC, Smith DS. Recurrence phenotypes and establishment of latency following rabbit keratitis produced by multiple herpes simplex virus strains. J Gen Virol. 1983;64:2441.PubMedCrossRefGoogle Scholar
  212. 212.
    Sanitato JJ, Asbell PA, Varnell ED, et al. Acyclovir in the treatment of herpetic stromal disease. Am J Ophthalmol. 1984;98:537.PubMedGoogle Scholar
  213. 213.
    Panzardi D. Contributo alla conoscenza delle lesioni erpetishe oculari: su di un particolare caso di ­compromissiono della conjunctiva, cornea ed episclera da virus erpetico. Bolletino d’Oculistica. 1947;26:465.Google Scholar
  214. 214.
    Saba V. Sullo episcleriti erpetishe: contributo clinico. Ann Ottalmol Clin Ocul. 1947;73:168.Google Scholar
  215. 215.
    Sanna M. Episclerite erpetica. Bolletino d’Oculistica. 1950;29:173.Google Scholar
  216. 216.
    La Lau C, Oosterhuis JA, Versteeg J, et al. Acyclovir and trifluorothymidine in herpetic keratitis. Preliminary report of a multicentered trial. Doc Ophthalmol. 1981;50:287.PubMedCrossRefGoogle Scholar
  217. 217.
    La Lau C, Oosterhuis JA, Versteeg J, et al. Multicenter clinical trial of acyclovir and trifluorothymidine inW herpetic keratitis. Am J Med. 1982;(Acyclovir Symposium):305–306.Google Scholar
  218. 218.
    Foster CS, Barney NP. Systemic acyclovir and ­penetrating keratoplasty for herpes simplex keratitis. Doc Ophthalmol. 1992;80:363.Google Scholar
  219. 219.
    Meyer RF, Sullivan JH, Oh JO. Mumps conjunctivitis. Am J Ophthalmol. 1974;78:1022.PubMedGoogle Scholar
  220. 220.
    Berg F. Scleritis pericornealis nach Parotitis epidemica. Berichte uber die Versammlungen der deutschen ophthalmologischen Gesellschaft. 1927;46:368.Google Scholar
  221. 221.
    Rieger M. Uber subconjunctivitis epibulbaris ­metastatica bei Parotitis epidemica. Archiv für Ophthalmologie. 1935;133:505.CrossRefGoogle Scholar
  222. 222.
    North DP. Ocular complications of mumps. Br J Ophthalmol. 1953;37:99.PubMedCrossRefGoogle Scholar
  223. 223.
    Swan KC, Penn RF. Scleritis following mumps. Report of a case. Am J Ophthalmol. 1962;53:366.PubMedGoogle Scholar
  224. 224.
    Berger ST, Mondino BJ, Hoft RH, et al. Successful medical management of Acanthamoeba keratitis. Am J Ophthalmol. 1990;110:395.PubMedGoogle Scholar
  225. 225.
    Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol. 2009;48:487.CrossRefGoogle Scholar
  226. 226.
    Ebrahimi KB, Green WR, Grebe R, Jun AS. Acanthamoeba sclerokeratitis. Graefes Arch Clin Exp Ophthalmol. 2009;247:283.PubMedCrossRefGoogle Scholar
  227. 227.
    Pineda 2nd R, Kocatürk T, Bhui RD. Visual outcome and rehabilitation in a case of bilateral acanthamoeba sclerokeratitis. Cornea. 2007;26:1150.PubMedCrossRefGoogle Scholar
  228. 228.
    Chang PCT, Soong HK. Acanthamoeba keratitis in non-contact lens wearers. Arch Ophthalmol. 1991;109:463.PubMedGoogle Scholar
  229. 229.
    Sharma S, Srinivasan M, George C. Acanthamoeba keratitis in non-contact lens wearers. Arch Ophthalmol. 1990;108:676.PubMedCrossRefGoogle Scholar
  230. 230.
    Theodore FH, Jakobiec FA, Juechter KB, et al. The diagnostic value of a ring infiltrate in Acanthamoeba keratitis. Ophthalmology. 1985;92:1471.PubMedGoogle Scholar
  231. 231.
    Moore MB, McCulley JP, Kaufman HE, et al. Radial keratoneuritis as a presenting sign in Acanthamoeba keratitis. Ophthalmology. 1986;93:1310.PubMedGoogle Scholar
  232. 232.
    Wilhelmus KR, Osato MS, Font RL, et al. Rapid diagnosis of Acanthamoeba keratitis using calcofluor white. Arch Ophthalmol. 1986;104:1309.PubMedCrossRefGoogle Scholar
  233. 233.
    Marines HM, Osato MS, Font RL. The value of calcofluor white in the diagnosis of mycotic and Acanthamoeba infections of the eye and ocular adnexa. Ophthalmology. 1987;94:23.PubMedGoogle Scholar
  234. 234.
    Epstein RJ, Wilson LA, Visvesvara GS. Rapid diagnosis of Acanthamoeba keratitis from corneal scrapings using indirect fluorescent antibody staining. Arch Ophthalmol. 1986;104:1318.PubMedCrossRefGoogle Scholar
  235. 235.
    Hoft RH, Mondino BJ. The diagnosis and clinical management of Acanthamoeba keratitis. Semin Ophthalmol. 1991;6:106.CrossRefGoogle Scholar
  236. 236.
    Ishibashi Y, Matsumoto Y, Kabata T. Oral itraconazol and topical miconazol with debridement for Acanthamoeba keratitis. Am J Ophthalmol. 1990;109:121.PubMedGoogle Scholar
  237. 237.
    Wilder HC. Toxocara chorioretinitis in adults. Arch Ophthalmol. 1952;48:127.CrossRefGoogle Scholar
  238. 238.
    Zimmerman LE. Ocular pathology of toxoplasmosis. Surv Ophthalmol. 1961;6:832.Google Scholar
  239. 239.
    Tokuda H, Okamura R, Kamano H. A case of brawny scleritis caused by Toxoplasma gondii. Rinsho Ganka. 1970;24:565.Google Scholar
  240. 240.
    Shuman JS, Weinberg RS, Ferry AP, et al. Toxo­plasmic scleritis. Ophthalmology. 1988;95:1399.Google Scholar
  241. 241.
    Raistrick ER, Hart JCD. Ocular toxocariasis in adults. Br J Ophthalmol. 1976;60:365.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Maite Sainz de la Maza
    • 1
  • Joseph Tauber
    • 2
  • C. Stephen Foster
    • 3
  1. 1.Clinical Institute of OphthalmologyHospital Clinic of BarcelonaBarcelonaSpain
  2. 2.Tauber Eye CenterKansas CityUSA
  3. 3.Massachusetts Eye Research and Surgery InstitutionCambridgeUSA

Personalised recommendations